Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer

April 30, 2024 0

From Akero Therapeutics Andrew Cheng, M.D., Ph.D., president and chief executive officer of Akero Therapeutics remarked, …

INmune Bio Inc. Update on Two Alzheimer Disease Patients Who Continued to Receive XPro Product

April 30, 2024 0

INmune Bio Press Release INmune Bio (NASDAQ: INMB) is pleased to share an update on two …

U.S. FDA Approved Pfizer’s BEQVEZ™ – A One-Time Gene Therapy for Adults with Hemophilia B

April 26, 2024 0

Pfizer Approval A one-time dose of the Pfizer product, BEQVEZ, has reduced bleeds post-treatment compared to …

Vertex and TreeFrog Therapeutics Announced Licensing Agreement and Collaboration to Optimize Production of Vertex Cell Therapies for Type 1 Diabetes

April 25, 2024 0

Vertex Pharmaceuticals and TreeFrog Therapeutics in the NEWS Vertex Pharmaceuticals (VRTX) and TreeFrog Therapeutics announced that …

Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases

April 25, 2024 0

Regeneron Pharmaceuticals and Mammoth Biosciences in the NEWS Regeneron Pharmaceuticals (REGN) and Mammoth Biosciences, Inc. announced a …

The U.S. FDA Approved Immunity Bio’s ANKTIVA® for the Treatment of BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

April 23, 2024 0

Immunity Bio in the NEWS Immunity Bio (IBRX) - an immunotherapy company, announced that the U.S. …

Cerevel Therapeutics Announces Positive Results for Tavapadon in Phase 3 Adjunctive Trial for Parkinson’s Disease

April 20, 2024 0

Cerevel Therapeutics in the NEWS Cerevel Therapeutics (CERE) announced positive topline results from its pivotal Phase …

Vertex Pharmaceuticals Announces Advancements of Its Product Suzetrigine for Acute and Neuropathic Pain

April 18, 2024 0

Vertex Pharmaceuticals in the NEWS Vertex Pharmaceuticals (VRTX) announced advancements across its suzetrigine pain program, which …

Voyager Therapeutics: Demonstrating Productivity in Collaboration with Neurocrine to Advance Gene Therapies for Neurological Diseases

April 17, 2024 0

Voyager Therapeutics Voyager Therapeutics (VYGR) is a biotech company dedicated to leveraging the power of human …

Answers About Vertex Pharmaceuticals Acquisition of Alpine Immune. See Also: Important News from Coya Therapeutics on ALS

April 11, 2024 0

Vertex Pharmaceuticals Acquisition of Alpine Immune Sciences We start this posting by answering a question by …

Syndax Pharmaceuticals: Positive Pediatric Data from Pivotal Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia at ASPHO Plenary Session

April 9, 2024 0

Syndax Pharmaceuticals in the NEWS Yesterday, Syndax Pharmaceuticals (NASDAQ: SNDX) announced the presentation of positive data …

Madrigal Pharmaceuticals Announces U.S. Availability of its Newly Approved Product Rezdiffra

April 9, 2024 0

Madrigal Pharmaceuticals in the NEWS Today, April 09, 2024, Madrigal Pharmaceuticals (MDGL) announced that its NASH …

Johnson & Johnson to Acquire Shockwave Medical

April 5, 2024 0

Johnson & Johnson in the NEWS Today, Apr. 5, 2024 - Johnson & Johnson (JNJ) and …

BioStem Technologies’ Press Release and Conference Call Offered Encouraging News

April 2, 2024 0

BioStem Technologies Inc From Jason Matuszewski, CEO of BioStem Technologies (BSEM), who stated, “BioStem had an …

BioStem Technologies is Releasing its Fourth Quarter 2023 Financial Results Now

April 1, 2024 0

BioStem Technologies to Release Fourth Quarter Results BioStem Technologies (BSEM) is hosting a conference call and …

Verrica Pharmaceuticals Announced the FDA Granted YCANTHTM New Chemical Entity Status and Orange Book Listing

March 28, 2024 0

We are currently working to bring into the upcoming ProhostBiotech Letter some small clinical and commercial …

AbbVie Inc’s Two Different, Yet, Positive Impacting News

March 26, 2024 0

AbbiVie Inc's Acquisition and Approval 1. AbbVie's Acquisition AbbVie Inc. (ABBV) and Landos Biopharma, Inc. …

Novo Nordisk Aims to Acquire Cardior Pharmaceuticals, Strengthening Its Pipeline in Cardiovascular Disease

March 25, 2024 0

Novo Nordisk in the NEWS Novo Nordisk (NVO) and Cardior Pharmaceuticals announced that Novo Nordisk agreed …

Italfarmaco Received FDA Approval for Duvyzat™ for the Treatment of Duchenne Muscular Dystrophy

March 22, 2024 0

Italfarmaco in the NEWS From Milan, Italy: Today, Italfarmaco announced that the U.S. Food and Drug …

Illumina Stock Price Will Rebound With or Without This News

March 22, 2024 0

Illumina in the NEWS On March 21, 2024, we learned that the EU antitrust regulators suffered …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer

INmune Bio Inc. Update on Two Alzheimer Disease Patients Who Continued to Receive XPro Product

U.S. FDA Approved Pfizer’s BEQVEZ™ – A One-Time Gene Therapy for Adults with Hemophilia B

Vertex and TreeFrog Therapeutics Announced Licensing Agreement and Collaboration to Optimize Production of Vertex Cell Therapies for Type 1 Diabetes

Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases

The U.S. FDA Approved Immunity Bio’s ANKTIVA® for the Treatment of BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Cerevel Therapeutics Announces Positive Results for Tavapadon in Phase 3 Adjunctive Trial for Parkinson’s Disease

Vertex Pharmaceuticals Announces Advancements of Its Product Suzetrigine for Acute and Neuropathic Pain

Voyager Therapeutics: Demonstrating Productivity in Collaboration with Neurocrine to Advance Gene Therapies for Neurological Diseases

Answers About Vertex Pharmaceuticals Acquisition of Alpine Immune. See Also: Important News from Coya Therapeutics on ALS

Syndax Pharmaceuticals: Positive Pediatric Data from Pivotal Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia at ASPHO Plenary Session

Madrigal Pharmaceuticals Announces U.S. Availability of its Newly Approved Product Rezdiffra

Johnson & Johnson to Acquire Shockwave Medical

BioStem Technologies’ Press Release and Conference Call Offered Encouraging News

BioStem Technologies is Releasing its Fourth Quarter 2023 Financial Results Now

Verrica Pharmaceuticals Announced the FDA Granted YCANTHTM New Chemical Entity Status and Orange Book Listing

AbbVie Inc’s Two Different, Yet, Positive Impacting News

Novo Nordisk Aims to Acquire Cardior Pharmaceuticals, Strengthening Its Pipeline in Cardiovascular Disease

Italfarmaco Received FDA Approval for Duvyzat™ for the Treatment of Duchenne Muscular Dystrophy

Illumina Stock Price Will Rebound With or Without This News